- Home
- WIMI vs DARE Comparison
WIMI vs DARE Comparison
Compare WIMI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- DARE
- Stock Information
- Founded
- WIMI 2015
- DARE 2015
- Country
- WIMI China
- DARE United States
- Employees
- WIMI 107
- DARE N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- DARE Health Care
- Exchange
- WIMI Nasdaq
- DARE Nasdaq
- Market Cap
- WIMI 23.9M
- DARE 26.3M
- IPO Year
- WIMI 2020
- DARE N/A
- Fundamental
- Price
- WIMI $3.53
- DARE $2.52
- Analyst Decision
- WIMI
- DARE Strong Buy
- Analyst Count
- WIMI 0
- DARE 3
- Target Price
- WIMI N/A
- DARE $12.50
- AVG Volume (30 Days)
- WIMI 7.6M
- DARE 443.5K
- Earning Date
- WIMI 01-01-0001
- DARE 08-11-2025
- Dividend Yield
- WIMI N/A
- DARE N/A
- EPS Growth
- WIMI N/A
- DARE N/A
- EPS
- WIMI N/A
- DARE N/A
- Revenue
- WIMI $84,137,968.00
- DARE $25,909.00
- Revenue This Year
- WIMI N/A
- DARE $99,756.91
- Revenue Next Year
- WIMI N/A
- DARE $119.77
- P/E Ratio
- WIMI N/A
- DARE N/A
- Revenue Growth
- WIMI 19.25
- DARE N/A
- 52 Week Low
- WIMI $0.27
- DARE $2.11
- 52 Week High
- WIMI $2.92
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- WIMI 60.88
- DARE 41.75
- Support Level
- WIMI $2.73
- DARE $2.37
- Resistance Level
- WIMI $3.09
- DARE $2.54
- Average True Range (ATR)
- WIMI 0.26
- DARE 0.14
- MACD
- WIMI 0.15
- DARE -0.00
- Stochastic Oscillator
- WIMI 83.58
- DARE 59.56
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.